Identification and isolation of somatic stem cells and uses thereof

Details for Australian Patent Application No. 2002355970 (hide)

Owner The Peter MacCallum Cancer Institute

Inventors Simmons, Paul John

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002355970

PCT Number PCT/AU02/01101

PCT Pub. Number WO2003/016916

Priority PR 7036 15.08.01 AU

Filing date 15 August 2002

Wipo publication date 3 March 2003

Acceptance publication date 23 October 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/23 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/28 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Marrow

A61K 35/30 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Nerves

A61K 35/32 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Bones

A61K 35/36 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Skin

A61K 35/39 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/407 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 35/48 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Reproductive organs

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/04 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): PR 7036 15.08.01 AU

29 May 2003 Application Open to Public Inspection

  Published as AU-B-2002355970

23 October 2008 Application Accepted

  Published as AU-B-2002355970

22 January 2009 Assignment before Grant

  The Peter MacCallum Cancer Institute The application has been assigned to The Peter MacCallum Cancer Institute; Medvet Science Pty. Ltd. 2003

19 February 2009 Standard Patent Sealed

12 March 2009 Alteration of Name

  The name of the patentee has been altered to Peter MacCallum Cancer Institute; Medvet Science Pty. Ltd.

15 March 2012 Assignment Registered

  Medvet Science Pty. Ltd.; Peter MacCallum Cancer Institute The patent has been assigned to Mesoblast, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002355971-SYSTEM AND METHOD FOR DETERMINING AUDIENCE CHARACTERISTICS

2002355969-Optic fibre support device